NCT07178262

Brief Summary

Hystrectomy is a surgical procedure that involves removal of uterus from the body of patient using a lower abdominal incision. This is an extremely painful procedure which causes discomfort and greatly increases opioids consumption in the peri-operative period. This can be reduced by using nerve blocks such as Erector spinae plane block.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Aug 2025

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 31, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

September 17, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2025

Completed
Last Updated

September 17, 2025

Status Verified

August 1, 2025

Enrollment Period

3 months

First QC Date

August 31, 2025

Last Update Submit

September 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total Intra-operative Fentanyl consumption

    From surgical incision till end of surgery

Secondary Outcomes (2)

  • Total amount of IV Tramadol consumed in post operative period

    First 24 hours after surgery

  • Post operative pain score

    Baseline that is pain score upon arrival in post anesthesia care unit in the post operative period and then at 1hours ,2 hours ,4 hours,6 hours,12 hours and 24 hours in the post operative period

Study Arms (2)

Erector spinae group

ACTIVE COMPARATOR

Patients in this group will receive bilateral erector spinae block at T10 level using 30ml of 0.25% Bupivacaine before surgical incision.

Drug: Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)

Placebo

PLACEBO COMPARATOR

Patient in this group will receive Norma saline in Erector spinae block at T10 level bilaterally before surgical incision.

Drug: Placebo

Interventions

Bilateral Erector Spinae Block at T10 level using 30ml of 0.25% Bupivacaine will be administered under Ultrasound guidance before surgical incision.

Erector spinae group

Bilateral Erector Spinae Block at T10 level using 30ml of Normal saline will be administered under Ultrasound guidance before surgical incision.

Placebo

Eligibility Criteria

Age16 Years - 80 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists (ASA) class: I, II and III .
  • Elective Hysterectomy under General Anesthesia.

You may not qualify if:

  • Lack of consent
  • Body mass index \>35 kg/m2
  • Allergic to study medicine
  • Opioid abuse or misuse disorder
  • Chronic pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kulsoom Internation Hospital

Islamabad, Federal, 44000, Pakistan

RECRUITING

Related Publications (1)

  • Hamed MA, Boules ML, Mahmoud MAEM, Abdelghaffar RA. The effect of erector spinae plane block on fentanyl consumption during open abdominal hysterectomy: a randomised controlled study. BMC Anesthesiol. 2023 Jun 5;23(1):194. doi: 10.1186/s12871-023-02156-3.

    PMID: 37277703BACKGROUND

MeSH Terms

Interventions

ParapsychologyDental OcclusionBupivacaine

Intervention Hierarchy (Ancestors)

Behavioral SciencesBehavioral Disciplines and ActivitiesDentistryDental Physiological PhenomenaDigestive System and Oral Physiological PhenomenaAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Central Study Contacts

Waqas Anjum, Principal Investigator, MBBS, FCPS

CONTACT

Abdul Rehman, MBBS,FCPS

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 31, 2025

First Posted

September 17, 2025

Study Start

August 1, 2025

Primary Completion

October 30, 2025

Study Completion

October 30, 2025

Last Updated

September 17, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations